ConductScience.org, home

Paper41113636

Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy.

Miszkiewicz-Golec J and 5 others. Front Microbiol, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy. Papers, record 41113636. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41113636

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hammerhead ribozymes directed against mRNA of an essential gene inhibit Escherichia coli growth and enhance tetracycline efficacy.
PubMed
Journal
Front Microbiol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-10-22
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miszkiewicz-Golec JJoanna
2Maximowa KKsenia
3Łukaszewicz MMaciej
4Bartosik DDariusz
5Darżynkiewicz EEdward
6Trylska JJoanna

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118154538Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.Clin Microbiol Infect2008https://conductscience.org/library/papers/18154538PubMed
27489494Inhibition of the hammerhead ribozyme by neomycin.RNA1995https://conductscience.org/library/papers/7489494PubMed
312718910Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.Mol Ther2003https://conductscience.org/library/papers/12718910PubMed
415025910The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli.Oligonucleotides2003https://conductscience.org/library/papers/15025910PubMed
524137305Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria.Exp Ther Med2013https://conductscience.org/library/papers/24137305PubMed
63487247Synergism and antagonism in double beta-lactam antibiotic combinations.Am J Med1986https://conductscience.org/library/papers/3487247PubMed
77505618The hammerhead RNA domain, a model ribozyme.Biochim Biophys Acta1993https://conductscience.org/library/papers/7505618PubMed
88781957Detection of hammerhead ribozyme-mediated cleavage and reduced expression of LacZ' mRNA in E. coli.Genet Anal1996https://conductscience.org/library/papers/8781957PubMed
930534121Artificial Activation of Escherichia coli mazEF and hipBA Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy.Front Microbiol2018https://conductscience.org/library/papers/30534121PubMed
1021097888Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA.Nucleic Acids Res2011https://conductscience.org/library/papers/21097888PubMed
1110446190Hammerhead ribozyme cleavage of apolipoprotein B mRNA generates a truncated protein.J Biol Chem1999https://conductscience.org/library/papers/10446190PubMed
128948630In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II.Nucleic Acids Res1996https://conductscience.org/library/papers/8948630PubMed
1322539264Automated 3D structure composition for large RNAs.Nucleic Acids Res2012https://conductscience.org/library/papers/22539264PubMed
1410371033Ribozymes: the characteristics and properties of catalytic RNAs.FEMS Microbiol Rev1999https://conductscience.org/library/papers/10371033PubMed
1510890453Plasmid effects on Escherichia coli metabolism.Crit Rev Biotechnol2000https://conductscience.org/library/papers/10890453PubMed
1611454858An extra nucleotide in the consensus catalytic core of a viroid hammerhead ribozyme: implications for the design of more efficient ribozymes.J Biol Chem2001https://conductscience.org/library/papers/11454858PubMed
1731296387Structure and dynamics of human and bacterial acyl carrier proteins and their interactions with fatty acid synthesis proteins.Biochem Biophys Res Commun2019https://conductscience.org/library/papers/31296387PubMed
1828794451Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells.Sci Rep2017https://conductscience.org/library/papers/28794451PubMed
198744570VMD: visual molecular dynamics.J Mol Graph1996https://conductscience.org/library/papers/8744570PubMed
2011024182Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts.Nucleic Acids Res2000https://conductscience.org/library/papers/11024182PubMed

See all 91 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41113636

GET https://conductscience.org/api/papers/v1/41113636/references?page=2